China's medical technology sector is racing to weave artificial intelligence into hospital equipment — but at least one major player says it is deliberately pumping the brakes.
According to Reuters, United Imaging Intelligence, an AI-focused subsidiary of Chinese medical technology giant Shanghai United Imaging Healthcare, is taking a cautious approach to deploying AI tools. The company's co-CEO said the firm is not undertaking an "extreme" AI rollout, framing its strategy as measured rather than aggressive.
The reporting, filed from Shanghai and also carried by outlets including WSAU, is brief on specifics. It does not detail which tools are affected, a timeline, or the reasoning the co-CEO gave beyond the characterization of the approach as restrained.
What stands out is the tone. Much of the industry conversation around AI in healthcare has emphasized speed and scale. A senior executive at a large imaging company publicly describing his firm's rollout as deliberately not "extreme" runs against that grain — a signal that some established players see value in moving carefully when AI is applied to medical diagnostics, where errors carry real consequences for patients.
United Imaging Healthcare is one of China's largest makers of medical imaging systems such as CT and MRI scanners, making its subsidiary's posture a notable data point on how the country's medical technology leaders are pacing themselves.
Why it matters: AI is being pushed into hospitals worldwide at speed, so a major Chinese imaging firm publicly choosing caution over an "extreme" rollout hints that even eager adopters are weighing safety and trust against the rush to deploy.